1. "Urology"
Formats
  1. Journal Article (3000)
  2. Meeting Abstract (1004)
  3. Book Section (177)
  4. Editorial (93)
  5. Review (87)
  6. Correspondence (45)
  7. Conference Paper (33)
  8. Guidelines (33)
  9. Book Whole (18)
  10. Research Letter (12)
  11. Miscellaneous (5)
Groups
  1. Surgery (4507)
  2. Urology (4507)
  3. Population Sciences Research Program (1155)
  4. Epidemiology and Biostatistics (1046)
  5. Department of Medicine (855)
  6. Solid Tumor Oncology Division (807)

More Groups

People
  1. Peter Scardino (671)
  2. John Mulhall (601)
  3. Harry Herr (594)
  4. Paul Russo (581)
  5. James Eastham (537)
  6. Victor Reuter (474)

More People

Years
  1. 2025 (63)
  2. 2024 (163)
  3. 2023 (142)
  4. 2022 (160)
  5. 2021 (175)
  6. 2020 (174)

More Years

Publications
  1. Journal of Urology (538)
  2. Journal of Clinical Oncology (392)
  3. Journal of Sexual Medicine (373)
  4. European Urology (314)
  5. Urology (245)
  6. BJU International (227)

More Publications

Publishers
  1. Elsevier Science, Inc. (1158)
  2. Elsevier Inc. (637)
  3. American Society of Clinical Oncology (403)
  4. Wiley Blackwell (388)
  5. Nature Publishing Group (257)
  6. Springer (213)

More Publishers

Results (4507)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable cancer control in high risk prostate cancer patients treated with radical prostatectomy
    Meeting Abstract

    Graefen, M.; Walz, J.; Gallina, A.; Chun, F.; Reuther, A.; Eastham, J. S.; Klein, E.; Scardino, P. S.; Montorsi, F. S.; Huland, H.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Larger prostate glands are associated with a lower rate of upgrading between biopsy and radical prostatectomy
    Meeting Abstract

    Gallina, A.; Walz, J.; Trinh, Q. D.; Friedrich, M.; Scattoni, V.; Eastham, J.; Scardino, P.; Graefen, M.; Montorsi, F.; Rigatti, P.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Clinicians can accurately select patients in whom lymphadenectomy may be safely omitted at radical prostatectomy
    Meeting Abstract

    Gallina, A.; Walz, J.; Raber, M.; Ahyai, S. A.; Klein, E.; Reuther, A.; Eastham, J. A.; Scardino, P. T.; Graefen, M.; Montorsi, F.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • No differences in biochemical recurrence between no and NX patients subjected to radical prostatectomy: A matched analyses on 5977 patients
    Meeting Abstract

    Gallina, A.; Walz, J.; Heinzer, H.; Klein, E.; Reuther, A.; Eastham, J. A.; Da Pozzo, L. F. S.; Montorsi, F. S.; Graefen, M.; Huland, H.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Comparison of stage migration patterns between north america and Europe: An analysis of 11350 men
    Meeting Abstract

    Gallina, A.; Walz, J.; Hutterer, G. C.; Shariat, S. F.; Klein, E.; Eastham, J. A.; Da Pozzo, L. F.; De La Taille, A.; Rigatti, P.; Graefen, M.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Positive surgical margins increase the risk of biochemical recurrence independently from pathological stage or grade
    Meeting Abstract

    Gallina, A.; Walz, J.; Eichelberg, C.; Zanni, G.; Reuther, A.; Klein, E.; Eastham, J. A. S.; Scardino, P. T.; Perrotte, P. S.; Montorsi, F.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Impact of surgical margin length, number and gleason on biochemical recurrence for men undergoing radical prostatectomy
    Meeting Abstract

    Carver, B. S.; Romero Otero, J.; Kuroiwa, K.; Serio, A.; Scardino, P. T.; Eastham, J. A.
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Tumor-associated trypsin inhibitor (TATI, SPINK1), but not trypsinogen-1, is associated with outcome after radical prostatectomy as evaluated by oligonucleotide and tissue microarrays in prostate cancer
    Meeting Abstract

    Bjartell, A.; Serio, A.; Al-Ahmadie, H.; Eastham, J.; Eggener, S.; Fine, S.; Hotakainen, K.; Satagopan, J.; Stenman, U. H.; Gerald, W.; more...
    BJU International (2007)

    Fulltext@MSK | Save
  • Prediction of outcome after radical prostatectomy using a tissue microarray of 947 primary prostate cancers and immunohistochemical detection of cysteine-rich secretory protein 3 (CRISP-3) and beta-microseminoprotein (MSP)
    Meeting Abstract

    Bjartell, A.; Al-Ahmadie, H.; Serio, A.; Eastham, J.; Eggener, S.; Fine, S.; Udby, L.; Gerald, W.; Vickers, A.; Lilja, H.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save